Picture1.png
CBIH Files Petition to Include Alexis Bortell as Witness in DEA Rescheduling Hearing
16. Dezember 2024 08:00 ET | CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.
CBIH has formally filed a petition to have Ms. Alexis Bortell serve as a witness in the upcoming DEA hearing on marijuana rescheduling.
Picture1.png
CBIH Strengthens Clinical Research Team in Preparation for Launch of Next-Generation Cannabinoid Solutions
18. November 2024 08:00 ET | CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.
Cannabis Bioscience International Holdings (OTCMKTS: CBIH) continues to invest in top-tier talent as it prepares to launch its specialized pharmaceutical a
Picture1.png
CBIH advances Cancer Care with Novel Cannabis Patents for Breast and Pancreatic Cancers
01. Juli 2024 08:00 ET | CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.
Cannabis Bioscience International Holdings (OTCMKTS: CBIH) is excited to announce the submission of our inaugural pair of patents, focusing on novel treatm
CBIH and Vita Biotech Forge Alliance to Propel Clinical Studies Forward
05. Juni 2024 15:12 ET | CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.
“Collaboration in clinical trials ensures data integrity and safety, advancing both organizations' missions and improving patient care,” says Dr. Jennifer